Mice lacking sialyltransferase ST3Gal-II develop late-onset obesity and insulin resistance

Autores
Lopez, Pablo; Aja, Susan; Aoki, Kazuhiro; Seldin, Marcus M.; Lei, Xia; Ronnett, Gabriele V; Wong, G. William; Schnaar, Ronald L.
Año de publicación
2017
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Sialyltransferases are a family of 20 gene products in mice and humans that transfer sialic acid from its activated precursor, CMP-sialic acid, to the terminus of glycoprotein and glycolipid acceptors. ST3Gal-II (coded by the St3gal2 gene) transfers sialic acid preferentially to the three positions of galactose on the Galβ1-3GalNAc terminus of gangliosides GM1 and GD1b to synthesize GD1a and GT1b, respectively. Mice with a targeted disruption of St3gal2 unexpectedly displayed lateonset obesity and insulin resistance. At 3 months of age, St3gal2-null mice were the same weight as their wild type (WT) counterparts, but by 13 months on standard chow they were visibly obese, 22% heavier and with 37% greater fat/lean ratio than WT mice. St3gal2-null mice became hyperglycemic and displayed impaired glucose tolerance by 9 months of age. They had sharply reduced insulin responsiveness despite equivalent pancreatic islet morphology. Analyses of insulin receptor (IR) tyrosine kinase substrate IRS-1 and downstream target Akt revealed decreased insulininduced phosphorylation in adipose tissue but not liver or skeletal muscle of St3gal2-null mice. Thin-layer chromatography and mass spectrometry revealed altered ganglioside profiles in the adipose tissue of St3gal2-null mice compared to WT littermates. Metabolically, St3gal2-null mice display a reduced respiratory exchange ratio compared to WT mice, indicating a preference for lipid oxidation as an energy source. Despite their altered metabolism, St3gal2-null mice were hyperactive. We conclude that altered ganglioside expression in adipose tissue results in diminished IR sensitivity and late-onset obesity.
Fil: Lopez, Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Investigación Médica Mercedes y Martín Ferreyra. Universidad Nacional de Córdoba. Instituto de Investigación Médica Mercedes y Martín Ferreyra; Argentina. Johns Hopkins University School of Medicine; Estados Unidos
Fil: Aja, Susan. Johns Hopkins University School of Medicine; Estados Unidos
Fil: Aoki, Kazuhiro. University of Georgia; Grecia
Fil: Seldin, Marcus M.. Johns Hopkins University School of Medicine; Estados Unidos
Fil: Lei, Xia. Johns Hopkins University School of Medicine; Estados Unidos
Fil: Ronnett, Gabriele V. Johns Hopkins University School of Medicine; Estados Unidos
Fil: Wong, G. William. Johns Hopkins University School of Medicine; Estados Unidos
Fil: Schnaar, Ronald L.. Johns Hopkins University School of Medicine; Estados Unidos
Materia
ADIPOSE TISSUE
GANGLIOSIDE
HYPERGLYCEMIA
METABOLISM
SIALIC ACID
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/63851

id CONICETDig_2984c44584abb7f31daa758e30784033
oai_identifier_str oai:ri.conicet.gov.ar:11336/63851
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Mice lacking sialyltransferase ST3Gal-II develop late-onset obesity and insulin resistanceLopez, PabloAja, SusanAoki, KazuhiroSeldin, Marcus M.Lei, XiaRonnett, Gabriele VWong, G. WilliamSchnaar, Ronald L.ADIPOSE TISSUEGANGLIOSIDEHYPERGLYCEMIAMETABOLISMSIALIC ACIDhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Sialyltransferases are a family of 20 gene products in mice and humans that transfer sialic acid from its activated precursor, CMP-sialic acid, to the terminus of glycoprotein and glycolipid acceptors. ST3Gal-II (coded by the St3gal2 gene) transfers sialic acid preferentially to the three positions of galactose on the Galβ1-3GalNAc terminus of gangliosides GM1 and GD1b to synthesize GD1a and GT1b, respectively. Mice with a targeted disruption of St3gal2 unexpectedly displayed lateonset obesity and insulin resistance. At 3 months of age, St3gal2-null mice were the same weight as their wild type (WT) counterparts, but by 13 months on standard chow they were visibly obese, 22% heavier and with 37% greater fat/lean ratio than WT mice. St3gal2-null mice became hyperglycemic and displayed impaired glucose tolerance by 9 months of age. They had sharply reduced insulin responsiveness despite equivalent pancreatic islet morphology. Analyses of insulin receptor (IR) tyrosine kinase substrate IRS-1 and downstream target Akt revealed decreased insulininduced phosphorylation in adipose tissue but not liver or skeletal muscle of St3gal2-null mice. Thin-layer chromatography and mass spectrometry revealed altered ganglioside profiles in the adipose tissue of St3gal2-null mice compared to WT littermates. Metabolically, St3gal2-null mice display a reduced respiratory exchange ratio compared to WT mice, indicating a preference for lipid oxidation as an energy source. Despite their altered metabolism, St3gal2-null mice were hyperactive. We conclude that altered ganglioside expression in adipose tissue results in diminished IR sensitivity and late-onset obesity.Fil: Lopez, Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Investigación Médica Mercedes y Martín Ferreyra. Universidad Nacional de Córdoba. Instituto de Investigación Médica Mercedes y Martín Ferreyra; Argentina. Johns Hopkins University School of Medicine; Estados UnidosFil: Aja, Susan. Johns Hopkins University School of Medicine; Estados UnidosFil: Aoki, Kazuhiro. University of Georgia; GreciaFil: Seldin, Marcus M.. Johns Hopkins University School of Medicine; Estados UnidosFil: Lei, Xia. Johns Hopkins University School of Medicine; Estados UnidosFil: Ronnett, Gabriele V. Johns Hopkins University School of Medicine; Estados UnidosFil: Wong, G. William. Johns Hopkins University School of Medicine; Estados UnidosFil: Schnaar, Ronald L.. Johns Hopkins University School of Medicine; Estados UnidosOxford Univ Press Inc2017-01-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/63851Lopez, Pablo; Aja, Susan; Aoki, Kazuhiro; Seldin, Marcus M.; Lei, Xia; et al.; Mice lacking sialyltransferase ST3Gal-II develop late-onset obesity and insulin resistance; Oxford Univ Press Inc; Glycobiology; 27; 1; 5-1-2017; 129-1390959-66581460-2423CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1093/glycob/cww098info:eu-repo/semantics/altIdentifier/url/https://academic.oup.com/glycob/article/27/2/129/2585095info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:51:43Zoai:ri.conicet.gov.ar:11336/63851instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:51:43.891CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Mice lacking sialyltransferase ST3Gal-II develop late-onset obesity and insulin resistance
title Mice lacking sialyltransferase ST3Gal-II develop late-onset obesity and insulin resistance
spellingShingle Mice lacking sialyltransferase ST3Gal-II develop late-onset obesity and insulin resistance
Lopez, Pablo
ADIPOSE TISSUE
GANGLIOSIDE
HYPERGLYCEMIA
METABOLISM
SIALIC ACID
title_short Mice lacking sialyltransferase ST3Gal-II develop late-onset obesity and insulin resistance
title_full Mice lacking sialyltransferase ST3Gal-II develop late-onset obesity and insulin resistance
title_fullStr Mice lacking sialyltransferase ST3Gal-II develop late-onset obesity and insulin resistance
title_full_unstemmed Mice lacking sialyltransferase ST3Gal-II develop late-onset obesity and insulin resistance
title_sort Mice lacking sialyltransferase ST3Gal-II develop late-onset obesity and insulin resistance
dc.creator.none.fl_str_mv Lopez, Pablo
Aja, Susan
Aoki, Kazuhiro
Seldin, Marcus M.
Lei, Xia
Ronnett, Gabriele V
Wong, G. William
Schnaar, Ronald L.
author Lopez, Pablo
author_facet Lopez, Pablo
Aja, Susan
Aoki, Kazuhiro
Seldin, Marcus M.
Lei, Xia
Ronnett, Gabriele V
Wong, G. William
Schnaar, Ronald L.
author_role author
author2 Aja, Susan
Aoki, Kazuhiro
Seldin, Marcus M.
Lei, Xia
Ronnett, Gabriele V
Wong, G. William
Schnaar, Ronald L.
author2_role author
author
author
author
author
author
author
dc.subject.none.fl_str_mv ADIPOSE TISSUE
GANGLIOSIDE
HYPERGLYCEMIA
METABOLISM
SIALIC ACID
topic ADIPOSE TISSUE
GANGLIOSIDE
HYPERGLYCEMIA
METABOLISM
SIALIC ACID
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Sialyltransferases are a family of 20 gene products in mice and humans that transfer sialic acid from its activated precursor, CMP-sialic acid, to the terminus of glycoprotein and glycolipid acceptors. ST3Gal-II (coded by the St3gal2 gene) transfers sialic acid preferentially to the three positions of galactose on the Galβ1-3GalNAc terminus of gangliosides GM1 and GD1b to synthesize GD1a and GT1b, respectively. Mice with a targeted disruption of St3gal2 unexpectedly displayed lateonset obesity and insulin resistance. At 3 months of age, St3gal2-null mice were the same weight as their wild type (WT) counterparts, but by 13 months on standard chow they were visibly obese, 22% heavier and with 37% greater fat/lean ratio than WT mice. St3gal2-null mice became hyperglycemic and displayed impaired glucose tolerance by 9 months of age. They had sharply reduced insulin responsiveness despite equivalent pancreatic islet morphology. Analyses of insulin receptor (IR) tyrosine kinase substrate IRS-1 and downstream target Akt revealed decreased insulininduced phosphorylation in adipose tissue but not liver or skeletal muscle of St3gal2-null mice. Thin-layer chromatography and mass spectrometry revealed altered ganglioside profiles in the adipose tissue of St3gal2-null mice compared to WT littermates. Metabolically, St3gal2-null mice display a reduced respiratory exchange ratio compared to WT mice, indicating a preference for lipid oxidation as an energy source. Despite their altered metabolism, St3gal2-null mice were hyperactive. We conclude that altered ganglioside expression in adipose tissue results in diminished IR sensitivity and late-onset obesity.
Fil: Lopez, Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Investigación Médica Mercedes y Martín Ferreyra. Universidad Nacional de Córdoba. Instituto de Investigación Médica Mercedes y Martín Ferreyra; Argentina. Johns Hopkins University School of Medicine; Estados Unidos
Fil: Aja, Susan. Johns Hopkins University School of Medicine; Estados Unidos
Fil: Aoki, Kazuhiro. University of Georgia; Grecia
Fil: Seldin, Marcus M.. Johns Hopkins University School of Medicine; Estados Unidos
Fil: Lei, Xia. Johns Hopkins University School of Medicine; Estados Unidos
Fil: Ronnett, Gabriele V. Johns Hopkins University School of Medicine; Estados Unidos
Fil: Wong, G. William. Johns Hopkins University School of Medicine; Estados Unidos
Fil: Schnaar, Ronald L.. Johns Hopkins University School of Medicine; Estados Unidos
description Sialyltransferases are a family of 20 gene products in mice and humans that transfer sialic acid from its activated precursor, CMP-sialic acid, to the terminus of glycoprotein and glycolipid acceptors. ST3Gal-II (coded by the St3gal2 gene) transfers sialic acid preferentially to the three positions of galactose on the Galβ1-3GalNAc terminus of gangliosides GM1 and GD1b to synthesize GD1a and GT1b, respectively. Mice with a targeted disruption of St3gal2 unexpectedly displayed lateonset obesity and insulin resistance. At 3 months of age, St3gal2-null mice were the same weight as their wild type (WT) counterparts, but by 13 months on standard chow they were visibly obese, 22% heavier and with 37% greater fat/lean ratio than WT mice. St3gal2-null mice became hyperglycemic and displayed impaired glucose tolerance by 9 months of age. They had sharply reduced insulin responsiveness despite equivalent pancreatic islet morphology. Analyses of insulin receptor (IR) tyrosine kinase substrate IRS-1 and downstream target Akt revealed decreased insulininduced phosphorylation in adipose tissue but not liver or skeletal muscle of St3gal2-null mice. Thin-layer chromatography and mass spectrometry revealed altered ganglioside profiles in the adipose tissue of St3gal2-null mice compared to WT littermates. Metabolically, St3gal2-null mice display a reduced respiratory exchange ratio compared to WT mice, indicating a preference for lipid oxidation as an energy source. Despite their altered metabolism, St3gal2-null mice were hyperactive. We conclude that altered ganglioside expression in adipose tissue results in diminished IR sensitivity and late-onset obesity.
publishDate 2017
dc.date.none.fl_str_mv 2017-01-05
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/63851
Lopez, Pablo; Aja, Susan; Aoki, Kazuhiro; Seldin, Marcus M.; Lei, Xia; et al.; Mice lacking sialyltransferase ST3Gal-II develop late-onset obesity and insulin resistance; Oxford Univ Press Inc; Glycobiology; 27; 1; 5-1-2017; 129-139
0959-6658
1460-2423
CONICET Digital
CONICET
url http://hdl.handle.net/11336/63851
identifier_str_mv Lopez, Pablo; Aja, Susan; Aoki, Kazuhiro; Seldin, Marcus M.; Lei, Xia; et al.; Mice lacking sialyltransferase ST3Gal-II develop late-onset obesity and insulin resistance; Oxford Univ Press Inc; Glycobiology; 27; 1; 5-1-2017; 129-139
0959-6658
1460-2423
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1093/glycob/cww098
info:eu-repo/semantics/altIdentifier/url/https://academic.oup.com/glycob/article/27/2/129/2585095
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Oxford Univ Press Inc
publisher.none.fl_str_mv Oxford Univ Press Inc
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842269112881905664
score 13.13397